BioTuesdays

Giving healthcare companies and their stories the exposure they deserve.

Subscribe

THIS WEEK'S FEATURE

MORE FEATURES

BriaCell breast cancer program ready for partnering

Dr. Bill Williams, President and CEO BriaCell Therapeutics (OTCQB:BCTXD; TSXV:BCT) believes its Phase 2 clinical program in advanced breast cancer, which includes an ongoing combination study of its Bria-IMT with immune...


NEWS


Just a few of the companies we’ve highlighted along the way

coverage

Subscribe

Sign up to our weekly BioTuesdays newsletter.